Anti-Cancer Activity of Buthus occitanus Venom on Hepatocellular Carcinoma in 3D Cell Culture
Open Access
- 29 March 2022
- Vol. 27 (7), 2219
- https://doi.org/10.3390/molecules27072219
Abstract
Hepatocellular carcinoma (HCC) is the most dominant primary liver cancer, which can be caused by chronic hepatitis virus infections and other environmental factors. Resection, liver transplantation, and local ablation are only a few of the highly effective and curative procedures presently accessible. However, other complementary treatments can reduce cancer treatment side effects. In this present work, we evaluated the activity of Moroccan scorpion venom Buthus occitanus and its fractions obtained by chromatography gel filtration against HCC cells using a 3D cell culture model. The venom was fractionated by gel filtration chromatography, each fraction and the crude venom was tested on normal hepatocytes (Fa2N-4 cells). Additionally, the fractions and the crude venom were tested on MCTSs (multicellular tumor spheroids), and this latter was generated by cultivate Huh7.5 cancer cell line with WI38 cells, LX2 cells, and human endothelial cells (HUVEC). Our results indicate that Buthus occitanus venom toxin has no cytotoxic effects on normal hepatocytes. Moreover, it is reported that F3 fraction could significantly inhibit the MCTS cells. Other Protein Separation Techniques (High-performance liquid chromatography) are needed in order to identify the most active molecule.Funding Information
- the National Research foundation of Korea (NRF), grant funded by the Korea government (2017M3A9G7072864 and NRF-2017M3A9G6068246)
This publication has 47 references indexed in Scilit:
- Comparison between two methods of scorpion venom milking in MoroccoJournal of Venomous Animals and Toxins including Tropical Diseases, 2013
- Epidemiology of Viral Hepatitis and Hepatocellular CarcinomaGastroenterology, 2012
- Activation of JNK and high expression level of CD133 predict a poor response to sorafenib in hepatocellular carcinomaBritish Journal of Cancer, 2012
- Scorpion venom component III inhibits cell proliferation by modulating NF-κB activation in human leukemia cellsExperimental and Therapeutic Medicine, 2012
- Arthropod venoms and cancerToxicon, 2011
- Apoptogenic peptides from Tityus discrepans scorpion venom acting against the SKBR3 breast cancer cell lineToxicon, 2010
- Sorafenib in Advanced Hepatocellular CarcinomaThe New England Journal of Medicine, 2008
- Hepatocellular carcinoma as a complex polygenic disease. Interpretive analysis of recent developments on genetic predispositionBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2006
- Overview of scorpion toxins specific for Na+ channels and related peptides: biodiversity, structure–function relationships and evolutionToxicon, 2005
- Therapeutic potential of venom peptidesNature Reviews Drug Discovery, 2003